Publicaciones en colaboración con investigadores/as de KU Leuven (3)

2022

  1. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

    Annals of Oncology, Vol. 33, Núm. 1, pp. 67-79

2012

  1. Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial

    Annals of Oncology, Vol. 23, Núm. 7, pp. 1780-1788

  2. Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: A randomised phase II study

    British Journal of Cancer, Vol. 107, Núm. 3, pp. 435-441